Mandy Deimel brings extensive experience in the life sciences sector. She has held multiple Managing Director roles with full P&L responsibility across international organizations in pharma, diagnostics, biotech, and medical devices. Her expertise spans GxP compliance (GMP, GLP, GCLP), regulatory affairs, and pharmaceutical quality systems, and she has successfully led organizational restructuring, scale-up projects, and GMP-compliant clean room expansions. Mandy has also worked closely with regulatory bodies such as the FDA, EMA, and German authorities (e.g., LGL Bayern), ensuring operational excellence and compliance across all functions.
Most recently, Mandy served as Managing Director of the Pharma and Diagnostics Division at Eurofins Genomics Europe, overseeing several legal entities and driving strategic realignment and operational development. She holds an Executive MBA from the TUM School of Management, graduated with distinction, and is a certified Lean Six Sigma Black Belt, demonstrating her commitment to operational excellence, cultural change leadership, and sustainable growth.
